0001213900-24-004298.txt : 20240118 0001213900-24-004298.hdr.sgml : 20240118 20240118090833 ACCESSION NUMBER: 0001213900-24-004298 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240118 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240118 DATE AS OF CHANGE: 20240118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Incannex Healthcare Inc. CENTRAL INDEX KEY: 0001873875 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: C3 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41106 FILM NUMBER: 24540232 BUSINESS ADDRESS: STREET 1: 401 DOCKLANDS DRIVE STREET 2: SUITE 15, LEVEL 12 CITY: DOCKLANDS, VICTORIA STATE: C3 ZIP: 3008 BUSINESS PHONE: 61 409 840 786 MAIL ADDRESS: STREET 1: 401 DOCKLANDS DRIVE STREET 2: SUITE 15, LEVEL 12 CITY: DOCKLANDS, VICTORIA STATE: C3 ZIP: 3008 FORMER COMPANY: FORMER CONFORMED NAME: Incannex Healthcare Ltd DATE OF NAME CHANGE: 20210720 8-K 1 ea191799-8k_incannex.htm CURRENT REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report January 18, 2024

Incannex Healthcare Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-41106		93-2403210
(State or other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

Suite 105, 8 Century Circuit Norwest,

NSW 2153 Australia

Not applicable

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, including Area Code: +61 409 840 786

(Former Name or Former Address, if Changed Since Last Report): Not Applicable

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of exchange on which registered
Common Stock, $0.0001 par value per share		IXHL		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01

On January 18, 2024, Incannex Healthcare Inc. announced that it had completed dosing and treatment protocols for all 72 participants in the PsiGAD-1 clinical trial. Further information is included in the press release attached as Exhibit 99.1 hereto, which is incorporated by reference into this Item 8.01.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press Release of Incannex Healthcare Inc., dated January 18, 2024
104		Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Incannex Healthcare Inc.

Date: January 18, 2024		/s/ Joel Latham
	Name:	Joel Latham
	Title:	Chief Executive Officer and President

2

EX-99.1 2 ea191799ex99-1_incannex.htm PRESS RELEASE OF INCANNEX HEALTHCARE INC., DATED JANUARY 18, 2024

Exhibit 99.1

Date: January 18, 2024

Public Announcement (NASDAQ: IXHL)

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

Highlights:

●

72 patients treated at purpose-built facilities within Monash University, Melbourne, Australia.

●

Topline results from the trial anticipated within current Q1 2024.

●

FDA IND application is well-advanced after commencing preparations in August, 2023.

●

Independent documentary covering Monash Clinical Psychedelic Lab and PsiGAD research program to be released by SBS television network following 2 years of filming and production.

MELBOURNE, Australia and NEW YORK, USA, Jan 18, 2024 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine therapies is pleased to announce that it has completed dosing and treatment protocols for all 72 participants in the PsiGAD-1 clinical trial, the Company’s Phase 2 study evaluating its own psilocybin treatment program for patients with generalized anxiety disorder (GAD).

PsiGAD-1 is a randomised triple-blind active-placebo-controlled Phase 2 trial. The primary objective of the study is to determine whether a 7-week program of psilocybin-assisted psychotherapy for GAD is superior to active placebo-assisted psychotherapy in decreasing symptoms of GAD, as measured by the change in the Hamilton Anxiety Rating Scale (HAM-A) from baseline to week 11. Safety and tolerability were assessed, as well as other secondary objectives of efficacy and quality of life.

“We’re delighted to have completed all PsiGAD-1 treatments for our trial participants as we work towards finalising an FDA IND application to advance the development of this important treatment modality,” said Joel Latham, Chief Executive Officer and President of Incannex. “Generalised anxiety disorder is characterised by persistent, debilitating and excessive worry, affects millions of people globally, and has inadequate existing treatment options. We’re thankful to our research partners at Monash University who conducted a thorough and extensive clinical trial, screening 975 people and undertaking 174 psychedelic dosing sessions in one of the largest clinical trials of its kind.”

FDA IND Application Preparations for PsiGAD

In March of 2023, Incannex announced the interim analysis for the Phase 2 PsiGAD-1 clinical trial, which predicted a greater than 85% chance that the trial would show statically significant benefit for the psilocybin treatment arm versus the placebo arm at the conclusion of the trial period. An independent Data Safety Monitoring Board (DSMB) was tasked with confidentially reviewing the data for the first 37 out of 72 trial participants. At that time, the DSMB recommended no adjustments to the original study design or sample size and acknowledged no safety concerns in the operation of the trial.

Incannex commenced the process of drafting an FDA IND application in August 2023 in preparation of the receipt of topline results from the PsiGAD-1 clinical trial, and submission soon thereafter.

Incannex Healthcare Inc.

Level 39, Rialto South Tower, 525 Collins Street, Melbourne VIC 3000

Email: admin@incannex.com.au

Page 1 | 3

Date: January 18, 2024

Public Announcement (NASDAQ: IXHL)

Documentary on the Monash Clinical Psychedelic Lab to be released in Late February 2024

Commissioned by the Australian Special Broadcasting Service (SBS), a film production company has tracked the activities of the Monash Clinical Psychedelic Lab for over 2 years, producing a documentary that focuses on the PsiGAD research program. Psychedelics: Stepping into the Unknown is a feature documentary on the first psychedelic lab in Australia and key partner in Incannex’s psychedelic research program. The documentary is currently scheduled for release on the SBS streaming service in late February 2024, and aims to contribute to the awareness of mental health, psychedelic therapies, and the expertise required for safe delivery.

END

About Incannex Healthcare Inc.

Incannex is a clinical stage pharmaceutical development company that is developing unique medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, and pain, among other indications.

U.S. FDA approval and registration, subject to ongoing clinical success, is being pursued for each drug and therapy under development. Each indication under investigation currently has no, or limited, existing registered pharmacotherapy (drug) treatments available to the public and represent major global economic opportunities to Incannex and its shareholders.

Incannex has a strong patent filing strategy in place as it develops its products and therapies in conjunction with its medical and scientific advisory board and partners. The Company holds 20 granted patents and over 30 pending patent applications.

Website: www.incannex.com

Investors: investors@incannex.com.au

Forward-looking statements

This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements are made as of the date they were first issued and were based on current expectations and estimates, as well as the beliefs and assumptions of management. The forward-looking statements included in this press release represent Incannex's views as of the date of this press release. Incannex anticipates that subsequent events and developments may cause its views to change. Incannex undertakes no intention or obligation to update or revise any forward-looking statements, whether as of a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Incannex's views as of any date after the date of this press release.

Incannex Healthcare Inc.

Level 39, Rialto South Tower, 525 Collins Street, Melbourne VIC 3000

Email: admin@incannex.com.au

Page 2 | 3

Date: January 18, 2024

Public Announcement (NASDAQ: IXHL)

Contact Information:

Incannex Healthcare Inc.

Mr Joel Latham

Chief Executive Officer, President and Director

admin@incannex.com.au

Investor Relations Contact – United States

Alyssa Factor

Edison Group

+1 (860) 573 9637

afactor@edisongroup.com

Incannex Healthcare Inc.

Level 39, Rialto South Tower, 525 Collins Street, Melbourne VIC 3000

Email: admin@incannex.com.au

Page 3 | 3

GRAPHIC 3 ex99-1_001.jpg GRAPHIC begin 644 ex99-1_001.jpg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end EX-101.SCH 4 ixhl-20240118.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 ixhl-20240118_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 ixhl-20240118_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	Jan. 18, 2024
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Jan. 18, 2024
Entity File Number	001-41106
Entity Registrant Name	Incannex Healthcare Inc.
Entity Central Index Key	0001873875
Entity Tax Identification Number	93-2403210
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	Suite 105
Entity Address, Address Line Two	8 Century Circuit Norwest
Entity Address, City or Town	NSW
Entity Address, Country	AU
Entity Address, Postal Zip Code	2153
City Area Code	+61
Local Phone Number	409 840 786
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	IXHL
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

XML 8 ea191799-8k_incannex_htm.xml IDEA: XBRL DOCUMENT 0001873875 2024-01-18 2024-01-18 iso4217:USD shares iso4217:USD shares false 0001873875 8-K 2024-01-18 Incannex Healthcare Inc. DE 001-41106 93-2403210 Suite 105 8 Century Circuit Norwest NSW 2153 AU +61 409 840 786 false false false false Common Stock, $0.0001 par value per share IXHL NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://incannex.com.au/role/Cover Cover Cover 1 false false All Reports Book All Reports ea191799-8k_incannex.htm ixhl-20240118.xsd ixhl-20240118_lab.xml ixhl-20240118_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea191799-8k_incannex.htm": { "nsprefix": "IXHL", "nsuri": "http://incannex.com.au/20240118", "dts": { "inline": { "local": [ "ea191799-8k_incannex.htm" ] }, "schema": { "local": [ "ixhl-20240118.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "ixhl-20240118_lab.xml" ] }, "presentationLink": { "local": [ "ixhl-20240118_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://incannex.com.au/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-01-18", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea191799-8k_incannex.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-18", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea191799-8k_incannex.htm", "first": true, "unique": true } } }, "tag": { "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://incannex.com.au/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001213900-24-004298-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-24-004298-xbrl.zip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end